Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Advanced Osteolytic Lesions (OL), Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM)

Mariam M Boota, MD, Rashid Z Khan, MD, Eric R Rosenbaum, MD MPH, Ahmed Abuabdou, MD, Chris W Williams, Bart Barlogie, MD PhD, Michele Cottler-Fox, MD

Blood (2014) 124 (21): 3858.

https://doi.org/10.1182/blood.V124.21.3858.3858

Published: 2014

Journal Articles

Validation of a Predictive Formula for Collection of Hematopoietic Progenitor Cells (HPC) By Leukapheresis at 2 Institutions Using 4 Different Machine Protocols

Eric R Rosenbaum, MD MPH, Patrick Wuchter, MD, Michael Hundemer, MD, Petra Pavel, MD, Mathias Witzens-Harig, MD, Hartmut Goldschmidt, MD, Bart Barlogie, MD PhD, Anthony Ho, MD, Michele H. Cottler-Fox, MD

Blood (2014) 124 (21): 2458.

https://doi.org/10.1182/blood.V124.21.2458.2458

Published: 2014

Journal Articles

Risk Of Myelodysplastic Syndrome (MDS) After Hematopoietic Progenitor Cell Collection Using Plerixafor

Rashid Z Khan, MD, Eric R Rosenbaum, MD, MPH, Mariam M Boota, Saad Z Usmani, MD, FACP, Bart Barlogie, MD, PhD, Michele Cottler-Fox, M.D.

Blood (2013) 122 (21): 4650.

https://doi.org/10.1182/blood.V122.21.4650.4650

Published: 2013

Journal Articles

Percent cPRA (calculated Panel Reactive Antibody) Value Predicts Percent Positive Platelet Crossmatches

Soumya Pandey, MD, Eric R Rosenbaum, MD, MPH, Michele Cottler-Fox, MD, Terry O Harville, MD PhD

Blood (2012) 120 (21): 3436.

https://doi.org/10.1182/blood.V120.21.3436.3436

Published: 2012

Journal Articles

A Better Mobilization Regimen for Newly Diagnosed Multiple Myeloma Patients,

Ahmed Y Abuabdou, MD, Eric R Rosenbaum, MD, MPH, Saad Usmani, MD, FACP, Bart Barlogie, MD, Ph.D, Michele Cottler-Fox, MD

Blood (2011) 118 (21): 4051.

https://doi.org/10.1182/blood.V118.21.4051.4051

Published: 2011

Journal Articles

Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers

Eric R Rosenbaum, MD, MPH, Mayumi Nakagawa, MD, PhD, Gina Pesek, MD, John W Theus, MD, Bart Barlogie, MD, PhD, Michele H. Cottler-Fox, MD

Blood (2011) 118 (21): 4388.

https://doi.org/10.1182/blood.V118.21.4388.4388

Published: 2011

NARROW

Advanced Osteolytic Lesions (OL), Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM)

Validation of a Predictive Formula for Collection of Hematopoietic Progenitor Cells (HPC) By Leukapheresis at 2 Institutions Using 4 Different Machine Protocols

Risk Of Myelodysplastic Syndrome (MDS) After Hematopoietic Progenitor Cell Collection Using Plerixafor

Percent cPRA (calculated Panel Reactive Antibody) Value Predicts Percent Positive Platelet Crossmatches

A Better Mobilization Regimen for Newly Diagnosed Multiple Myeloma Patients,

Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers

Email alerts

ASH Publications

American Society of Hematology

Advanced Osteolytic Lesions (OL), Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM)

Validation of a Predictive Formula for Collection of Hematopoietic Progenitor Cells (HPC) By Leukapheresis at 2 Institutions Using 4 Different Machine Protocols

Risk Of Myelodysplastic Syndrome (MDS) After Hematopoietic Progenitor Cell Collection Using Plerixafor

Percent cPRA (calculated Panel Reactive Antibody) Value Predicts Percent Positive Platelet Crossmatches

A Better Mobilization Regimen for Newly Diagnosed Multiple Myeloma Patients,

Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only